Literature DB >> 6752201

Activation of coagulation factor V by a platelet protease.

W H Kane, J S Mruk, P W Majerus.   

Abstract

Factor V must be converted to Factor V(a) in order to bind to a high affinity platelet surface site and participate in prothrombin activation. Osterud et al. (10) presented data that suggested that human platelets contain an activated form of Factor V and a Factor V activator. We find that the Factor V released when platelets are disrupted by freezing and thawing or sonication is activated 3- to 10-fold by thrombin as determined by coagulation assay and is therefore stored as the relatively inactive procofactor rather than in the active form Factor V(a). We incubated purified Factor V, which had a specific activity of 140+/-30 U/mg, with Factor V-deficient frozen and thawed platelets (10(9) platelets/ml) obtained from a patient with Factor V deficiency. The specific activity of the Factor V increased to a maximum of 740+/-240 U/mg (mean+/-SD of three experiments). When this partially activated Factor V was incubated with thrombin its specific activity increased further to 1,440+/-280 U/mg, which is similar to the activity of Factor V activated with thrombin alone (1,540+/-60 U/mg). The platelet Factor V activator is not inhibited by dansyl arginine-4-ethylpiperidine amide, 93 muM, indicating that it is not thrombin. When thrombin-stimulated platelets, to which dansyl arginine-4-ethylpiperidine amide had been added to inhibit the further action of thrombin, were incubated with (125)-labeled Factor V, there was no detectable proteolysis of the Factor V molecule. Our failure to detect activation of Factor V under these conditions suggests that <4% of the platelet protease is released by thrombin. Subcellular fractionation of platelets indicates that the platelet protease that activates Factor V is in the soluble fraction. When Factor V(a) formed by the action of platelet protease is incubated with platelets, peptides with M(r) = 105,000, 87,000, and 78,000 bind to the platelet surface. All three radiolabeled peptides are displaced from platelets by unlabeled Factor V(a) formed by the action of thrombin. The stoichiometry of binding suggests that the 105,000-dalton peptide is associated with either an 87,000- or a 78,000-dalton peptide. The 78,000-dalton peptide binds with greater affinity and probably accounts for the bulk of the activity of Factor V(a) in coagulation assays. Whether or not the platelet protease serves to activate Factor V before thrombin formation during normal hemostasis remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752201      PMCID: PMC370322          DOI: 10.1172/jci110697

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

Authors:  C DE DUVE; B C PRESSMAN; R GIANETTO; R WATTIAUX; F APPELMANS
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  The interaction of human coagulation factor Va with platelets.

Authors:  W H Kane; P W Majerus
Journal:  J Biol Chem       Date:  1982-04-10       Impact factor: 5.157

4.  Radioimmunoassay of factor V in human plasma and platelets.

Authors:  P B Tracy; L L Eide; E J Bowie; K G Mann
Journal:  Blood       Date:  1982-07       Impact factor: 22.113

5.  Subcellular localization and secretion of factor V from human platelets.

Authors:  C M Chesney; D Pifer; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

6.  Purification and characterization of human coagulation factor V.

Authors:  W H Kane; P W Majerus
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

7.  Release of human platelet factor V activity is induced by both collagen and ADP and is inhibited by aspirin.

Authors:  W J Vicic; B Lages; H J Weiss
Journal:  Blood       Date:  1980-09       Impact factor: 22.113

8.  Isolation of functional human coagulation factor V by using a hybridoma antibody.

Authors:  J A Katzmann; M E Nesheim; L S Hibbard; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

9.  Fibroblasts from patients with I-cell disease and pseudo-Hurler polydystrophy are deficient in uridine 5'-diphosphate-N-acetylglucosamine: glycoprotein N-acetylglucosaminylphosphotransferase activity.

Authors:  M L Reitman; A Varki; S Kornfeld
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

10.  Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C.

Authors:  M E Nesheim; W M Canfield; W Kisiel; K G Mann
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

View more
  6 in total

1.  Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.

Authors:  Fabian Stavenuiter; Nicole F Davis; Erning Duan; Andrew J Gale; Mary J Heeb
Journal:  Thromb Haemost       Date:  2012-12-13       Impact factor: 5.249

2.  Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.

Authors:  G M Rodgers; W H Kane
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

3.  Polyphosphate accelerates factor V activation by factor XIa.

Authors:  Sharon H Choi; Stephanie A Smith; James H Morrissey
Journal:  Thromb Haemost       Date:  2014-10-23       Impact factor: 5.249

4.  Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.

Authors:  Mettine H A Bos; Rodney M Camire
Journal:  J Coagul Disord       Date:  2010-07-01

5.  Prothrombinase complex assembly on the platelet surface is mediated through the 74,000-dalton component of factor Va.

Authors:  P B Tracy; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

6.  Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation.

Authors:  I Maruyama; H H Salem; P W Majerus
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.